» Authors » Murray A Mittleman

Murray A Mittleman

Explore the profile of Murray A Mittleman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 362
Citations 12046
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liou L, Mittleman M
J Med Educ Curric Dev . 2025 Feb; 12:23821205241279751. PMID: 39995618
Despite the widespread inclusion of statistics in medical school curricula as per the Liaison Committee on Medical Education requirements, the statistical competency among medical students and clinicians remains low. A...
2.
Wittenberg R, Mostofsky E, Mittleman M
Clin Transplant . 2025 Feb; 39(2):e70107. PMID: 39921596
Background: Transplantation is a critical treatment for end-stage heart disease and improves length and quality of life. We investigated predictors of functional status improvement following transplant and the association between...
3.
Zhang W, Redline S, Viswanathan A, Ascher S, Hari D, Juraschek S, et al.
Hypertension . 2025 Jan; PMID: 39840460
Background: Hypotensive episodes detected by 24-hour ambulatory blood pressure (BP) monitoring capture daily cumulative hypotensive stress and could be clinically relevant to cognitive impairment, but this relationship remains unclear. Methods:...
4.
Liou L, Mostofsky E, Lehman L, Salia S, Barrera F, Wei Y, et al.
PLoS One . 2025 Jan; 20(1):e0313600. PMID: 39775253
Although prediction models for heart transplantation outcomes have been developed previously, a comprehensive benchmarking of survival machine learning methods for mortality prognosis in the most contemporary era of heart transplants...
5.
Barrera Flores F, Mostofsky E, Salia S, Lehman L, Liou L, Mucci L, et al.
Int J Cardiol . 2024 Nov; 419:132691. PMID: 39521180
No abstract available.
6.
Wei Y, Mostofsky E, Barrera F, Liou L, Salia S, Pavlakis M, et al.
J Nephrol . 2024 Sep; 37(6):1689-1698. PMID: 39259484
Background: It remains unknown whether estimated glomerular filtration rate (eGFR) using the refit Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation without a term for race is associated with mortality and...
7.
Barrera F, Mostofsky E, Salia S, Lehman L, Liou L, Mucci L, et al.
Int J Cardiol . 2024 Aug; 415:132455. PMID: 39153512
Background: Heart transplant recipients develop cancer at two-times the rate compared to the general population. However, the incidence and mortality rates and the adjusted association between cancer and mortality remains...
8.
Wen T, Puett R, Liao D, Kanter J, Mittleman M, Lanzkron S, et al.
Environ Res . 2024 Apr; 252(Pt 1):118766. PMID: 38583660
Background: Sickle cell disease (SCD) is a genetic disorder and symptoms may be sensitive to environmental stressors. Although it has been hypothesized that exposure to outdoor air pollution could trigger...
9.
Slavin S, Berman A, Beam A, Navar A, Mittleman M
J Am Heart Assoc . 2024 Mar; 13(7):e032678. PMID: 38533942
Background: Many individuals eligible for statin therapy decline treatment, often due to fear of adverse effects. Misinformation about statins is common and drives statin reluctance, but its prevalence on social...
10.
Slavin S, Berman A, Gaba P, Hoshi R, Mittleman M
Am Heart J . 2023 Nov; 268:1-8. PMID: 37956919
Background: Influenza vaccination and lipid lowering therapy (LLT) are evidence-based interventions with substantial benefit for individuals with established atherosclerotic cardiovascular disease (ASCVD). However, levels of influenza immunization and LLT use...